These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3110033)

  • 21. The radioimmunoassay of a pregnancy specific-beta 1-glycoprotein in plasma as a pregnancy test for subfertile women.
    Anthony F; Masson GM; Wood PJ
    Br J Obstet Gynaecol; 1980 Jun; 87(6):496-50. PubMed ID: 6967326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentration of placental proteins in non-pregnant and pregnant subjects.
    Ahmed AG; Klopper A
    Arch Gynecol; 1985; 237(1):41-9. PubMed ID: 3876809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels of pregnancy specific beta 1-glycoprotein (SP1) in normal pregnancy and in intrauterine growth retardation.
    Lee JN; Huang SC; Ouyang PC; Wei PY; Al-Ani AT; Chard T
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):986-9. PubMed ID: 6973005
    [No Abstract]   [Full Text] [Related]  

  • 24. Pregnancy-specific beta 1-glycoprotein (SP1) levels measured by nephelometry in serum from women with vaginal bleeding in the first half of pregnancy.
    Tamsen L
    Acta Obstet Gynecol Scand; 1984; 63(4):311-5. PubMed ID: 6611014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of pregnancy from bloodstains by radioimmunoassay for pregnancy specific beta 1-glycoprotein (SP1).
    Yamamoto Y
    Nihon Hoigaku Zasshi; 1987 Aug; 41(4):279-93. PubMed ID: 3501027
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation].
    Briese V; Straube W
    Zentralbl Gynakol; 1984; 106(8):517-23. PubMed ID: 6203263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma pregnancy specific beta 1-glycoprotein (SP1) in pregnancy.
    Raman L; Pawashe AB
    Indian J Med Res; 1986 Aug; 84():223-6. PubMed ID: 2428748
    [No Abstract]   [Full Text] [Related]  

  • 28. Pitfall in the use of commercial kits for evaluating pregnancy-specific beta 1-glycoprotein (SP1).
    Decoster C; Vassart G
    Clin Chem; 1984 Nov; 30(11):1881. PubMed ID: 6333301
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of pregnancy-specific beta 1-glycoprotein (SP1) and ultrasound in predicting the date of delivery.
    Naiem A; Bersinger NA; Keller PJ; Schneider H
    Br J Obstet Gynaecol; 1988 Feb; 95(2):116-9. PubMed ID: 3280007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of pregnancy-specific beta 1-glycoprotein (SP1) containing complexes by mercaptoethanol.
    Sørensen S; Trentemøller S
    Clin Chim Acta; 1984 Sep; 142(1):137-43. PubMed ID: 6332688
    [No Abstract]   [Full Text] [Related]  

  • 31. Pregnancy-specific beta 1-glycoprotein (SP1) in serum and tissue from patients with benign and malignant breast tumours.
    Sørensen S; Andersen J; Nørgaard T
    Br J Cancer; 1984 May; 49(5):663-7. PubMed ID: 6609709
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of pregnancy-specific beta l glycoprotein and free estriol in the blood of pregnant women].
    Liu QX
    Zhonghua Fu Chan Ke Za Zhi; 1983 Jul; 18(3):142-5. PubMed ID: 6606540
    [No Abstract]   [Full Text] [Related]  

  • 33. A simple method for the measurement of pregnancy-specific beta 1-glycoprotein (SP1) using a latex agglutination inhibition technique.
    Nishiyama Y; Nose Y; Itoh M; Hayakawa S; Imaizumi H; Sawaki Y; Sugiyama Y
    Placenta; 1982; 3(2):137-44. PubMed ID: 6981807
    [No Abstract]   [Full Text] [Related]  

  • 34. Estimation of gestational age by last menstrual period, by ultrasound scan and by SP1 concentration: comparisons with date of delivery.
    Ahmed AG; Klopper A
    Br J Obstet Gynaecol; 1986 Feb; 93(2):122-7. PubMed ID: 3511954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of circulating pregnancy-specific beta 1 glycoprotein as a marker in carcinoma of the breast in women.
    Rosen SW; Gail MH; Tormey DC
    J Natl Cancer Inst; 1982 Nov; 69(5):1067-71. PubMed ID: 6982369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of serum SP1 levels in early normal and abnormal pregnancies].
    Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):95-7, 124-5. PubMed ID: 2364798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigations into the molecular heterogeneity of pregnancy-specific beta 1-glycoprotein (SP1).
    Hindersson P; Teisner B; Folkersen J; Grudzinskas JG; Westergaard JG
    Placenta; 1981; 2(3):233-40. PubMed ID: 6792620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SP-1: parameter for the high risk pregnancy. The pregnancy specific beta 1-glycoprotein in the serum of pregnant women with toxemia].
    Schumann K
    Fortschr Med; 1981 Feb; 99(6):188-91. PubMed ID: 6974125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme-linked immunoassay compared with electroimmunoassay for routine estimation of pregnancy-specific glycoprotein (SP1) in sera during pregnancy.
    Alexander LC
    Med Lab Sci; 1981 Mar; 38(2):77-83. PubMed ID: 6978453
    [No Abstract]   [Full Text] [Related]  

  • 40. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.